Healthy Living/WellnessEuropean Commission Approves Novartis Lung Cancer Drug Zykadia Swiss drug manufacturer Novartis announced that the European Commission has approved Zykadia (ceritinib), a drug used to treat patients suffering from an advanced form of non-small cell lung cancer.by Ted Ranosa
Healthy Living/WellnessResearchers Discover How Lung Cancer Spreads. Possible Clues to Halting Disease Progressionby Dianne Depra
Healthy Living/WellnessLung cancer can go undetected for at least 20 years before it turns deadlyby James Maynard
Standard Chartered to Cut 7,000 Back-Office Jobs by 2030: First Major Bank to Put AI on the Layoff Schedule